|
|
| (160 dazwischenliegende Versionen von einem Benutzer werden nicht angezeigt) |
| Zeile 1: |
Zeile 1: |
| | __NOTOC__ | | __NOTOC__ |
| | *'''[[Further reading]]''' | | *'''[[Further reading]]''' |
| | + | |
| | + | |
| | *'''[[Unproven ideas]]''' | | *'''[[Unproven ideas]]''' |
| | + | |
| | *'''[[Reviews on covid19 disease]]''' | | *'''[[Reviews on covid19 disease]]''' |
| − | {{tp|p=32240462|t=ä. Coronavirus disease 2019 (COVID-19): a clinical update |pdf=|usr=}}
| + | *'''[[Clinical guidelines and advice]]''' |
| − | {{tp|p=32318975|t=ä. Advances in COVID-19: the virus, the pathogenesis, and evidence-based control and therapeutic strategies |pdf=|usr=}}
| + | |
| − | {{tp|p=32363223|t=ä. Genomics functional analysis and drug screening of SARS-CoV-2 |pdf=|usr=}}
| + | |
| − | {{tp|p=32120965|t=2020. Outbreak of Novel Coronavirus (SARS-CoV-2): First Evidences From International Scientific Literature and Pending Questions |pdf=|usr=}}
| + | |
| | | | |
| − | *'''[[Research tools]]'''
| |
| − | {{tp|p=32142596|t=2020. Machine Learning, COVID?19 (2019?nCoV), and multi?OMICS |pdf=|usr=}}
| |
| − | {{tp|p=32187834|t=2020. ..COVID19: Cytometry and the New Challenge for Global Health |pdf=|usr=}}
| |
| − | {{tp|p=32270412|t=ä. Ultrarapid diagnosis, microscope imaging, genome sequencing, and culture isolation of SARS-CoV-2 |pdf=|usr=}}
| |
| | | | |
| − | *
| |
| − | *'''[[Structure of covid19]]'''
| |
| − | {{tp|p=32265007|t=2020. Whole genome and phylogenetic analysis of two SARS-CoV-2 strains isolated in Italy in January and February 2020: additional clues on multiple introductions and further circulation in Europe |pdf=|usr=}}
| |
| − | {{tp|p=32210741|t=2020. Unrevealing sequence and structural features of novel coronavirus using in silico approaches: The main protease as molecular target |pdf=|usr=}}
| |
| − | {{tp|p=32194944|t=2020. Prediction of the SARS-CoV-2 (2019-nCoV) 3C-like protease (3CL pro) structure: virtual screening reveals velpatasvir, ledipasvir, and other drug repurposing candidates |pdf=|usr=}}
| |
| − | {{tp|p=32300673|t=2020. Genomic characterization of a novel SARS-CoV-2 |pdf=|usr=}}
| |
| − | {{tp|p=32353474|t=ä. Genotyping coronavirus SARS-CoV-2: Methods and implications |pdf=|usr=}}
| |
| | | | |
| | + | *'''[[Respiration mgmt]]''' |
| | | | |
| | + | *'''[[Diagnosis (Laboratory)]]''' |
| | | | |
| − | *'''[[Target binding and uptake]]'''
| |
| − | {{tp|p=32220422|t=2020. The hosts angiotensin-converting enzyme polymorphism may explain epidemiological findings in COVID-19 infections |pdf=|usr=}}
| |
| − | {{tp|p=32336612|t=ä. The pivotal link between ACE2 deficiency and SARS-CoV-2 infection |pdf=|usr=}}
| |
| − | {{tp|p=32210742|t=2020. Role of changes in SARS-CoV-2 spike protein in the interaction with the human ACE2 receptor: An in silico analysis |pdf=|usr=}}
| |
| − | {{tp|p=32327200|t=ä. Covid-19 and the angiotensin-converting enzyme (ACE2): Areas for research |pdf=|usr=}}
| |
| | | | |
| | + | *'''[[Diagnosis (Lung CT, Sonography)]]''' |
| | | | |
| | + | *'''[[Diagnosis (other modalities)]]''' |
| | | | |
| | + | |
| | + | |
| | + | |
| | + | *'''[[Structure of covid19]]''' |
| | + | |
| | + | |
| | + | *'''[[Target binding and uptake]]''' |
| | *'''[[Cytopathic effects]]''' | | *'''[[Cytopathic effects]]''' |
| | *'''[[Secretion and shedding]]''' | | *'''[[Secretion and shedding]]''' |
| − | {{tp|p=32271376|t=ä. Factors associated with prolonged viral RNA shedding in patients with COVID-19 |pdf=|usr=}}
| + | |
| | + | |
| | | | |
| | *'''[[Innate sensing]]''' | | *'''[[Innate sensing]]''' |
| | + | |
| | *'''[[Immunology]]''' | | *'''[[Immunology]]''' |
| − | {{tp|p=32348472|t=ä. A Marker of Systemic Inflammation or Direct Cardiac Injury: Should Cardiac Troponin Levels be Monitored in COVID-19 Patients?|pdf=|usr=}}
| |
| − |
| |
| | | | |
| | *'''[[Cytokine storm, hemophagocytic lymphohistiocytosis, macrophage activation syndrome]]''' | | *'''[[Cytokine storm, hemophagocytic lymphohistiocytosis, macrophage activation syndrome]]''' |
| Zeile 44: |
Zeile 39: |
| | | | |
| | | | |
| − | *'''[[Microvascular]]''' | + | *'''[[Pathobiology]]''' |
| − | *
| + | |
| − | *'''[[Early symptoms]]'''
| + | |
| − | {{tp|p=32371463|t=2020. Clinicopathological characteristics of 8697 patients with COVID-19 in China: a meta-analysis |pdf=|usr=}}
| + | |
| | | | |
| − | *'''[[Systemic disease, any manifestations]]'''
| |
| − | *'''[[ARDS]]'''
| |
| | | | |
| − | *'''[[Pulmonary embolism, coagulation]]''' | + | *'''[[Disease Models]]''' |
| | | | |
| | | | |
| − | *'''[[Hematology]]''' | + | *'''[[Similar diseases and pathomechanisms]]''' |
| | | | |
| − | *'''[[Heart]]'''
| |
| − | {{tp|p=32354800|t=2020. Cardiovascular manifestations and treatment considerations in covid-19 |pdf=|usr=}}
| |
| − | {{tp|p=32305329|t=2020. Cardiovascular and Logistic Issues Associated With COVID-19 Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32373465|t=ä. Syncope as the presenting symptom of COVID-19 infection |pdf=|usr=}}
| |
| − | {{tp|p=32315757|t=ä. Current data on the cardiovascular effects of the COVID-19 |pdf=|usr=}}
| |
| | | | |
| − | *'''[[Neurology, ophthalmology, orl]]'''
| |
| − | {{tp|p=32367431|t=ä. Neurological manifestations of patients with COVID-19: potential routes of SARS-CoV-2 neuroinvasion from the periphery to the brain |pdf=|usr=}}
| |
| − | {{tp|p=32373061|t=2020. Triage of Acute Ischemic Stroke in Confirmed COVID-19: Large Vessel Occlusion Associated With Coronavirus Infection |pdf=|usr=}}
| |
| − | {{tp|p=32362868|t=2020. Long-Term Neurological Threats of COVID-19: A Call to Update the Thinking About the Outcomes of the Coronavirus Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32333104|t=ä. A child confirmed COVID-19 with only symptoms of conjunctivitis and eyelid dermatitis |pdf=|usr=}}
| |
| − | {{tp|p=32328758|t=ä. The prevalence of ophthalmic manifestations in COVID-19 and the diagnostic value of ocular tissue/fluid |pdf=|usr=}}
| |
| | | | |
| | | | |
| | + | *'''[[Early symptoms]]''' |
| | | | |
| − | *'''[[Dermatology]]''' | + | *'''[[Systemic disease, any manifestations]]''' |
| − | *'''[[Gastroenterology, hepatology]]'''
| + | |
| − | {{tp|p=32309266|t=2020. Abdominal Pain: A Real Challenge in Novel COVID-19 Infection |pdf=|usr=}}
| + | |
| − | {{tp|p=32142785|t=ä. COVID-19: Gastrointestinal Manifestations and Potential Fecal?Oral Transmission |pdf=|usr=}}
| + | |
| − | {{tp|p=32142773|t=ä. Evidence for Gastrointestinal Infection of SARS-CoV-2 |pdf=|usr=}}
| + | |
| − | {{tp|p=32199880|t=2020. Effect of Gastrointestinal Symptoms on Patients Infected With Coronavirus Disease 2019 |pdf=|usr=}}
| + | |
| − | {{tp|p=32251668|t=ä. Gastrointestinal Manifestations of SARS-CoV-2 Infection and Virus Load in Fecal Samples from the Hong Kong Cohort and Systematic Review and Meta-analysis |pdf=|usr=}}
| + | |
| − | {{tp|p=32353370|t=ä. Letter: Gastrointestinal ACE2, COVID-19 and IBD ? opportunity in the face of tragedy?|pdf=|usr=}}
| + | |
| − | {{tp|p=32348773|t=ä. COVID-19 and ACE2 in the liver and gastrointestinal tract: Putative biological explanations of sexual dimorphism |pdf=|usr=}}
| + | |
| − | {{tp|p=32333911|t=ä. Prevalence and Characteristics of Gastrointestinal Symptoms in Patients with SARS-CoV-2 Infection in the United States: A Multicenter Cohort Study |pdf=|usr=}}
| + | |
| − | {{tp|p=32330475|t=ä. Increased amylase and lipase in patients with COVID-19 pneumonia: dont blame the pancreas just yet!|pdf=|usr=}}
| + | |
| − | {{tp|p=32283099|t=ä. Why does SARS-CoV-2 invade the gastrointestinal epithelium?|pdf=|usr=}}
| + | |
| − | {{tp|p=32283101|t=ä. High Prevalence of Concurrent Gastrointestinal Manifestations in Patients with SARS-CoV-2: Early Experience from California |pdf=|usr=}}
| + | |
| − | {{tp|p=C7152871|t=ä. Gastrointestinal Symptoms and COVID-19: Case-Control Study from the United States |pdf=|usr=}}
| + | |
| − | {{tp|p=32283098|t=ä. COVID-19 and the liver: the perils of non-peer reviewed science in times of a pandemic |pdf=|usr=}}
| + | |
| − | {{tp|p=32247022|t=ä. Pancreatic injury patterns in patients with COVID-19 pneumonia |pdf=|usr=}}
| + | |
| − | {{tp|p=32213556|t=2020. Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms |pdf=|usr=}}
| + | |
| − | {{tp|p=32273292|t=2020. COVID-19 and the gastrointestinal tract: more than meets the eye |pdf=|usr=}}
| + | |
| − | {{tp|p=32312790|t=2020. Faecal calprotectin indicates intestinal inflammation in COVID-19 |pdf=|usr=}}
| + | |
| − | {{tp|p=32303609|t=2020. Covid-19 and immunomodulation in IBD |pdf=|usr=}}
| + | |
| | | | |
| | + | *'''[[Co-Infection]]''' |
| | | | |
| | | | |
| − | *'''[[Kidney, urology]]== | + | *'''[[Pulmonary embolism, coagulation]]''' |
| − | {{tp|p=32299479|t=2020. Acute kidney injury in SARS-CoV-2 infected patients |pdf=|usr=}}
| + | |
| − | {{tp|p=32197060|t=2020. Rhabdomyolysis as Potential Late Complication Associated with COVID-19 |pdf=|usr=}}
| + | |
| | | | |
| | | | |
| − | *
| |
| − | *'''[[Pathobiology]]'''
| |
| − | {{tp|p=32294179|t=ä. Coronavirus infections and type 2 diabetes-shared pathways with therapeutic implications |pdf=|usr=}}
| |
| − | {{tp|p=32293672|t=ä. Cell type-specific expression of the putative SARS-CoV-2 receptor ACE2 in human hearts |pdf=|usr=}}
| |
| − | {{tp|p=32350105|t=ä. Putative contributions of circadian clock and sleep in the context of SARS-CoV-2 infection |pdf=|usr=}}
| |
| − | {{tp|p=32341103|t=2020. Understanding the Renin-Angiotensin-Aldosterone-SARS-CoV-Axis: A Comprehensive Review |pdf=|usr=}}
| |
| − | {{tp|p=32198987|t=2020. Gross examination report of a COVID-19 death autopsy |pdf=|usr=}}
| |
| − | {{tp|p=32198986|t=2020. Review and Prospect of Pathological Features of Corona Virus Disease |pdf=|usr=}}
| |
| − | {{tp|p=32198985|t=2020. Guide to the Forensic Pathology Practice on Death Cases Related to Corona Virus Disease 2019 COVID-19 Trial Draft |pdf=|usr=}}
| |
| − | {{tp|p=32198984|t=2020. Academician Cong Bin: Autopsy of SARS-CoV-2 infection is needed to be strengthened |pdf=|usr=}}
| |
| − | {{tp|p=32198983|t=2020. From SARS-CoV to SARS-CoV-2: The response and challenge of forensic infectious disease autopsy |pdf=|usr=}}
| |
| − | {{tp|p=32170560|t=ä. Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection |pdf=|usr=}}
| |
| | | | |
| | | | |
| − | *'''[[Disease Models]]'''
| |
| − | {{tp|p=32215622|t=ä. Simulation of the clinical and pathological manifestations of Coronavirus Disease 2019 (COVID-19) in golden Syrian hamster model: implications for disease pathogenesis and transmissibility |pdf=|usr=}}
| |
| − | {{tp|p=32378471|t=2020. Animal models for emerging coronavirus: progress and new insights |pdf=|usr=}}
| |
| | | | |
| | + | *'''[[Hematology]]''' |
| | | | |
| − | *'''[[Similar diseases and pathomechanisms]]'''
| |
| − | {{tp|p=31859605|t=2020. Genetic manipulation of porcine deltacoronavirus reveals insights into NS6 and NS7 functions: a novel strategy for vaccine design |pdf=|usr=}}
| |
| − | {{tp|p=32186278|t=2020. Influenza-associated pneumonia as reference to assess seriousness of coronavirus disease (COVID-19) |pdf=|usr=}}
| |
| | | | |
| − | *
| |
| − | *'''[[Diagnosis (Laboratory)]]'''
| |
| | | | |
| | + | *'''[[Heart]]''' |
| | | | |
| − | *'''[[Diagnosis (Lung CT, Sonography)]]'''
| |
| − | {{tp|p=32204949|t=ä. An update on CT chest findings in coronavirus disease-19 (COVID-19) |pdf=|usr=}}
| |
| | | | |
| | | | |
| | + | *'''[[Neurology, ophthalmology, orl]]''' |
| | | | |
| − | *'''[[Diagnosis (other modalities)]]'''
| |
| − | {{tp|p=32276598|t=2020. Using echocardiography to guide the treatment of novel coronavirus pneumonia |pdf=|usr=}}
| |
| | | | |
| − | *'''[[Respiration mgmt]]'''
| |
| − | {{tp|p=32301347|t=ä. Extracorporeal membrane oxygenation therapy in the COVID-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32223988|t=ä. ECMO for ARDS due to COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32312554|t=ä. Early pulmonary rehabilitation for SARS-CoV-2 pneumonia: Experience from an intensive care unit outside of the Hubei province in China |pdf=|usr=}}
| |
| − | {{tp|p=32295710|t=ä. High flow nasal cannula is a good treatment option for COVID-19 |pdf=|usr=}}
| |
| | | | |
| | + | *'''[[Dermatology]]''' |
| | | | |
| | | | |
| − | *'''[[Clinical guidelines and advice]]'''
| |
| | | | |
| | + | *'''[[Gastroenterology, hepatology]]''' |
| | | | |
| − | {{tp|p=32307120|t=ä. Palliative care strategies offer guidance to clinicians and comfort for COVID-19 patient and families |pdf=|usr=}}
| + | *'''[[Kidney, urology]]''' |
| | + | |
| | + | *'''[[The morbid survivor]]''' |
| | | | |
| | *'''[[Risk and special populations]]''' | | *'''[[Risk and special populations]]''' |
| − | {{tp|p=32238084|t=2020. Vertical Transmission of Coronavirus Disease 19 (COVID-19) from Infected Pregnant Mothers to Neonates: A Review |pdf=|usr=}}
| |
| − | {{tp|p=32222253|t=2020. COVID-19: lessons from the Italian reproductive medical experience |pdf=|usr=}}
| |
| − | {{tp|p=32285380|t=ä. Clinical characteristics of 19 neonates born to mothers with COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32266184|t=2020. Infants Born to Mothers With a New Coronavirus (COVID-19) |pdf=|usr=}}
| |
| − | {{tp|p=32323577|t=ä. What the oncologist needs to know about COVID-19 infection in cancer patients |pdf=|usr=}}
| |
| − | {{tp|p=32322107|t=2020. SARS-CoV-2 Infection in Pregnancy ? a Review of the Current Literature and Possible Impact on Maternal and Neonatal Outcome |pdf=|usr=}}
| |
| − | {{tp|p=32357575|t=2020. COVID-19: A Geriatric Emergency |pdf=|usr=}}
| |
| − | {{tp|p=32357582|t=2020. Ageing and COVID-19: What is the Role for Elderly People?|pdf=|usr=}}
| |
| − | {{tp|p=32274617|t=2020. SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes |pdf=|usr=}}
| |
| − | {{tp|p=32199996|t=2020. Infection par le SARS-CoV-2 chez les femmes enceintes: etat des connaissances et proposition de prise en charge par CNGOF |pdf=|usr=}}
| |
| − | {{tp|p=32244059|t=ä. SARS-CoV-2, COVID-19 and inherited arrhythmia syndromes |pdf=|usr=}}
| |
| − | {{tp|p=32302703|t=ä. Considerations for Drug Interactions on QTc in Exploratory COVID-19 (Coronavirus Disease 2019) Treatment |pdf=|usr=}}
| |
| − | {{tp|p=32292696|t=ä. COVID-19 Infection Unmasking Brugada Syndrome |pdf=|usr=}}
| |
| | | | |
| − | {{tp|p=32325028|t=ä. G6PD deficiency in COVID-19 pandemic: ?a ghost in the ghost? |pdf=|usr=}}
| + | |
| | | | |
| | *'''[[Case reports]]''' | | *'''[[Case reports]]''' |
| − | {{tp|p=32241316|t=ä. Case Report on Early Diagnosis of COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32343659|t=2020. A Moderate Case of COVID-19 Viral Pneumonia During the SARS-CoV-2 Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32160149|t=2020. Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with 2019 Novel Coronavirus Disease, United States |pdf=|usr=}}
| |
| − | {{tp|p=32170559|t=ä. Combination of western medicine and Chinese traditional patent medicine in treating a family case of COVID-19 in Wuhan |pdf=|usr=}}
| |
| − | {{tp|p=32221725|t=ä. Brief report of the first cured 2019-nCoV pneumonia patient in West China Hospital |pdf=|usr=}}
| |
| | | | |
| − | *'''[[Case series]]'''
| |
| − | {{tp|p=32212512|t=2020. Retrospective Analysis of 61 Cases of Children Died of Viral Pneumonia |pdf=|usr=}}
| |
| − | {{tp|p=32363222|t=ä. The clinical and immunological features of pediatric COVID-19 patients in China |pdf=|usr=}}
| |
| | | | |
| | | | |
| | | | |
| − | *'''[[The morbid survivor]]''' | + | |
| − | {{tp|p=32329589|t=2020. Rehabilitation management of patients with COVID-19 Lessons learned from the first experiences in China |pdf=|usr=}}
| + | |
| − | {{tp|p=32316718|t=2020. Systematic rapid "living" review on rehabilitation needs due to covid-19: update to march 31st 2020 |pdf=|usr=}}
| + | |
| − | {{tp|p=32293817|t=2020. Rehabilitation and respiratory management in the acute and early post-acute phase "Instant paper from the field" on rehabilitation answers to the Covid-19 emergency |pdf=|usr=}}
| + | *'''[[Case series]]''' |
| − | {{tp|p=32217657|t=ä. Urgent need of a management plan for survivors of COVID-19 |pdf=|usr=}}
| + | |
| | + | |
| | + | *'''[[Registries]]''' |
| | | | |
| | | | |
| | *'''[[Trials]]''' | | *'''[[Trials]]''' |
| − | {{tp|p=C7102592|t=ä. Core Outcome Set for Clinical Trials on Coronavirus Disease 2019 (COS-COVID) |pdf=|usr=}}
| |
| | | | |
| | *'''[[Candidate Compounds Covid19]]''' | | *'''[[Candidate Compounds Covid19]]''' |
| − | {{tp|p=32374074|t=2020. Potential anti-SARS-CoV-2 drug candidates identified through virtual screening of the ChEMBL database for compounds that target the main coronavirus protease |pdf=|usr=}}
| + | |
| − | {{tp|p=32265848|t=2020. Subunit Vaccines Against Emerging Pathogenic Human Coronaviruses |pdf=|usr=}}
| + | |
| − | {{tp|p=32363145|t=ä. An algorithm for managing QT prolongation in coronavirus disease 2019 (COVID-19) patients treated with either chloroquine or hydroxychloroquine in conjunction with azithromycin: Possible benefits of intravenous lidocaine |pdf=|usr=}}
| + | |
| − | {{tp|p=32363144|t=ä. Inpatient use of mobile continuous telemetry for COVID-19 patients treated with hydroxychloroquine and azithromycin |pdf=|usr=}}
| + | |
| − | *'''[[Biophysics of aerosols]]'''
| + | |
| | *'''[[Other routes of infection]]''' | | *'''[[Other routes of infection]]''' |
| − | {{tp|p=32247692|t=ä. Faecal-oral transmission of SARS-COV-2: practical implications |pdf=|usr=}}
| + | |
| − | {{tp|p=32367287|t=ä. New evidence of SARS-CoV-2 transmission through the ocular surface |pdf=|usr=}}
| + | |
| − | {{tp|p=32363144|t=ä. Inpatient use of mobile continuous telemetry for COVID-19 patients treated with hydroxychloroquine and azithromycin |pdf=|usr=}}
| + | *'''[[Biophysics of aerosols]]''' |
| − | {{tp|p=32251729|t=ä. The Greek study in the effects of colchicine in COvid-19 complications prevention (GRECCO-19 study): Rationale and study design |pdf=|usr=}}
| + | |
| | + | |
| | + | |
| | | | |
| | *'''[[Passive protective equipment]]''' | | *'''[[Passive protective equipment]]''' |
| − | {{tp|p=32353457|t=ä. COVID-19 pandemic and personal protective equipment shortage: protective efficacy comparing masks and scientific methods for respirator reuse |pdf=|usr=}}
| |
| − | {{tp|p=32341947|t=ä. Masks and thermometers: Paramount measures to stop the rapid spread of SARS-CoV-2 in the United States |pdf=|usr=}}
| |
| − | {{tp|p=32221693|t=ä. Does hand hygiene reduce SARS-CoV-2 transmission?|pdf=|usr=}}
| |
| − | {{tp|p=32346616|t=2020. Frequent handwashing amidst the COVID?19 outbreak: prevention of hand irritant contact dermatitis and other considerations |pdf=|usr=}}
| |
| | | | |
| | | | |
| − | *
| + | |
| | *'''[[Running your hospital]]''' | | *'''[[Running your hospital]]''' |
| − | {{tp|p=32367256|t=ä. Nuclear medicine services after COVID-19: gearing up back to normality |pdf=|usr=}}
| |
| − | {{tp|p=32259155|t=2020. Covid 19 pandemic and gynaecological laparoscopic surgery: knowns and unknowns |pdf=|usr=}}
| |
| − | {{tp|p=32198988|t=2020. Safety protection of forensic examination during the epidemic of COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32198989|t=2020. Protection of forensic scene investigation and postmortem examination during the epidemic period of COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32267530|t=2020. COVID-19 and Family Doctors |pdf=|usr=}}
| |
| − | {{tp|p=32375144|t=2020. Fetal Diagnosis and Therapy during the COVID-19 Pandemic: Guidance on Behalf of the International Fetal Medicine and Surgery Society |pdf=|usr=}}
| |
| − | {{tp|p=32322146|t=2020. Aerosolization of COVID-19 and Contamination Risks During Respiratory Treatments |pdf=|usr=}}
| |
| − | {{tp|p=32295720|t=ä. Foot and Ankle Surgery during COVID-19 Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32356460|t=ä. Telemedicine for cancer patients during COVID-19 pandemic: between threats and opportunities |pdf=|usr=}}
| |
| − | {{tp|p=32323581|t=ä. The impact of the coronavirus pandemic on the management of cancer patients in Lebanon: a single institutional experience |pdf=|usr=}}
| |
| − | {{tp|p=32266838|t=ä. The Lebanese Society of Medical Oncology (LSMO) statement on the care of patients with cancer during the COVID-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32281756|t=2020. Covid-19 and its impact on nephropathic patients: the experience at Ospedale "Guglielmo da Saliceto" in Piacenza |pdf=|usr=}}
| |
| − | {{tp|p=32281755|t=2020. An account of the first hours of the Covid-19 epidemic at the Nephrology Unit in Lodi (Lombardy) |pdf=|usr=}}
| |
| − | {{tp|p=32371115|t=ä. German endoscopy unit preparations for the COVID-19 pandemic: A nationwide survey |pdf=|usr=}}
| |
| − | {{tp|p=32247018|t=ä. AGA Institute Rapid Recommendations for Gastrointestinal Procedures During the COVID-19 Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32314563|t=ä. Responding to COVID-19: Perspectives from the Chinese Society of Gastroenterology |pdf=|usr=}}
| |
| − | {{tp|p=32272113|t=ä. Management of Patients with Crohn?s Disease and Ulcerative Colitis During the COVID-19 Pandemic: Results of an International Meeting |pdf=|usr=}}
| |
| − | {{tp|p=32360567|t=ä. Inflammatory bowel disease management during the COVID-19 outbreak: a survey from the European Crohn?s and Colitis Organization (ECCO) |pdf=|usr=}}
| |
| − | {{tp|p=32353371|t=ä. Is SARS-CoV-2 Also an Enteric Pathogen with Potential Fecal-Oral Transmission: A COVID-19 Virological and Clinical Review |pdf=|usr=}}
| |
| − | {{tp|p=32348772|t=ä. Lay-off of Endoscopy services for the COVID-19 pandemic: how can we resume the practice of routine cases?|pdf=|usr=}}
| |
| − | {{tp|p=32330477|t=ä. Characteristics and prognosis of patients with inflammatory bowel disease during the SARS-CoV-2 pandemic in the Basque Country (Spain) |pdf=|usr=}}
| |
| − | {{tp|p=32305331|t=ä. Inflammatory bowel diseases and COVID-19: the invisible enemy |pdf=|usr=}}
| |
| − | {{tp|p=32283102|t=ä. Endoscopy units and the COVID-19 Outbreak: A Multi-Center Experience from Italy |pdf=|usr=}}
| |
| − | {{tp|p=32283100|t=ä. AGA Clinical Practice Update on Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: Expert Commentary |pdf=|usr=}}
| |
| − | {{tp|p=32234312|t=ä. COVID-19 in endoscopy: Time to do more?|pdf=|usr=}}
| |
| − | {{tp|p=32229132|t=ä. Separated pathways in the endoscopy unit for COVID-19 patients |pdf=|usr=}}
| |
| − | {{tp|p=32229131|t=ä. Considerations in performing endoscopy during the COVID-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32179106|t=ä. Coronavirus (COVID-19) outbreak: what the department of endoscopy should know |pdf=|usr=}}
| |
| − | {{tp|p=32268135|t=ä. Gastrointestinal endoscopy during COVID-19 pandemic: an updated review of guidelines and statements from international and national societies |pdf=|usr=}}
| |
| − | {{tp|p=32360302|t=2020. COVID-19 polymerase chain reaction testing before endoscopy: an economic analysis |pdf=|usr=}}
| |
| − | {{tp|p=32268134|t=ä. Preventing the spread of COVID-19 in digestive endoscopy during the resuming period: meticulous execution of screening procedures |pdf=|usr=}}
| |
| − | {{tp|p=32360301|t=ä. A proposal for the return to routine endoscopy during the COVID-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32339595|t=ä. Impact of the COVID-19 pandemic on endoscopy practice: results of a cross-sectional survey from the New York metropolitan area |pdf=|usr=}}
| |
| − | {{tp|p=32325065|t=ä. Management of upper GI bleeding in patients with COVID-19 pneumonia |pdf=|usr=}}
| |
| − | {{tp|p=32247754|t=ä. Use of a modified ventilation mask to avoid aerosolizing spread of droplets for short endoscopic procedures during coronavirus COVID-19 outbreak |pdf=|usr=}}
| |
| − | {{tp|p=32247755|t=ä. COVID-19 pandemic through the lens of a gastroenterology fellow: looking for the silver lining |pdf=|usr=}}
| |
| − | {{tp|p=32305346|t=ä. Plexiglass barrier box to improve ERCP safety during the COVID-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32305345|t=ä. ERCP during the pandemic of COVID-19 in Wuhan, China |pdf=|usr=}}
| |
| − | {{tp|p=32305344|t=ä. Resource-sparing urgent endoscopies by a mobile on-call team in the Paris area during the COVID-19 outbreak |pdf=|usr=}}
| |
| − | {{tp|p=32363326|t=2020. Mental healthcare for psychiatric inpatients during the COVID-19 epidemic |pdf=|usr=}}
| |
| − | {{tp|p=32374024|t=2020. Polish Society of Gynecology and Obstetrics statement on safety measures and performance of ultrasound examinations in obstetrics and gynecology during the SARS-CoV-2 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32367288|t=ä. Slit-lamp evaluation during SARS-CoV-2 pandemic: safety first!|pdf=|usr=}}
| |
| − | {{tp|p=32312738|t=2020. Contraception in the Era of COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32124000|t=ä. Stepping up infection control measures in ophthalmology during the novel coronavirus outbreak: an experience from Hong Kong |pdf=|usr=}}
| |
| − | {{tp|p=32232568|t=ä. Ocular manifestation, eye protection, and COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32346785|t=ä. Response of ophthalmologists in Israel to the novel coronavirus (2019-nCoV) outbreak |pdf=|usr=}}
| |
| − | {{tp|p=32328757|t=ä. Guidance for anti-VEGF intravitreal injections during the COVID-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32322965|t=ä. Communicating with patients with nAMD and their families during the COVID-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32322964|t=ä. Protective shields for ophthalmic equipment to minimise droplet transmission of COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32318805|t=ä. Treating neovascular age-related macular degeneration in the era of COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32314033|t=ä. Practical experience on emergency ophthalmic surgery during the prevalence of COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32314034|t=ä. Sustainable practice of ophthalmology during COVID-19: challenges and solutions |pdf=|usr=}}
| |
| − | {{tp|p=32303607|t=2020. British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32241901|t=2020. Prevention of nosocomial SARS-CoV-2 transmission in endoscopy: international recommendations and the need for a gold standard |pdf=|usr=}}
| |
| − | {{tp|p=32241897|t=2020. Practice of endoscopy during COVID-19 pandemic: position statements of the Asian Pacific Society for Digestive Endoscopy (APSDE-COVID statements) |pdf=|usr=}}
| |
| − | {{tp|p=32222433|t=ä. Recommandations pour la prise en charge chirurgicale des cancers gynecologiques en periode de pandemie COVID-19 - Groupe FRANCOGYN pour le CNGOF |pdf=|usr=}}
| |
| − | {{tp|p=32320812|t=ä. Prise en charge des cancers du sein pendant la pandemie de COVID 19: le CNGOF se mobilise |pdf=|usr=}}
| |
| − | {{tp|p=32311508|t=ä. La chirurgie gynecologique a l?xpreuve de l?infection COVID-19 Quelles recommandations formuler?|pdf=|usr=}}
| |
| − | {{tp|p=32370991|t=ä. COVID-19 and ovarian cancer: Exploring alternatives to intravenous (IV) therapies |pdf=|usr=}}
| |
| − | {{tp|p=32278932|t=2020. COVID-19: Initial experience of an international group of hand surgeons |pdf=|usr=}}
| |
| − | {{tp|p=32375887|t=2020. Challenges in maintaining treatment services for people who use drugs during the COVID-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32368710|t=2020. Responding to Healthcare Disparities and Challenges With Access to Care During COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32355634|t=ä. Health policy and technology challenges in responding to the COVID-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32196387|t=2020. Strategies to Inform Allocation of Stockpiled Ventilators to Healthcare Facilities During a Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32270054|t=2020. Hospital biopreparedness in the Looming Presence of SARS?CoV?2/COVID?19 |pdf=|usr=}}
| |
| − | {{tp|p=32371032|t=ä. Cardiovascular Disease in the Post-COVID-19 Era ? the Impending Tsunami?|pdf=|usr=}}
| |
| − | {{tp|p=32247013|t=ä. Guidance for Cardiac Electrophysiology During the Coronavirus (COVID-19) Pandemic from the Heart Rhythm Society COVID-19 Task Force; Electrophysiology Section of the American College of Cardiology; and the Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology, American Heart Association |pdf=|usr=}}
| |
| − | {{tp|p=C7196380|t=ä. Emergency Medical Services resource capacity and competency amid COVID-19 in the United States: Preliminary findings from a national survey |pdf=|usr=}}
| |
| − | {{tp|p=32313873|t=ä. How to manage lymphoid malignancies during novel 2019 coronavirus (CoVid-19) outbreak: a Brazilian task force recommendation |pdf=|usr=}}
| |
| | | | |
| | | | |
| | *'''[[Mental aspects of health professionals]]''' | | *'''[[Mental aspects of health professionals]]''' |
| − | {{tp|p=32342698|t=ä. Mental health care for medical staff and affiliated healthcare workers during the COVID-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32346406|t=2020. COVID-19 pandemic and its impact on mental health of healthcare professionals |pdf=|usr=}}
| |
| − | {{tp|p=32346373|t=2020. Survey of Insomnia and Related Social Psychological Factors Among Medical Staff Involved in the 2019 Novel Coronavirus Disease Outbreak |pdf=|usr=}}
| |
| − | {{tp|p=32351128|t=ä. COVID 19 outbreak: impact of the quarantine-induced stress on cardiovascular disease risk burden |pdf=|usr=}}
| |
| − |
| |
| | | | |
| | *'''[[Socio-psychiatric aspects of the status hygienicus]]''' | | *'''[[Socio-psychiatric aspects of the status hygienicus]]''' |
| − | {{tp|p=32363492|t=ä. Prevalence and socio-demographic correlates of psychological health problems in Chinese adolescents during the outbreak of COVID-19 |pdf=|usr=}}
| + | |
| − | {{tp|p=32371988|t=ä. COVID-19 pandemic: the effects of quarantine on cardiovascular risk |pdf=|usr=}}
| + | |
| − | {{tp|p=32335765|t=ä. Humanistic Epidemiology: Love in the time of cholera, COVID-19 and other outbreaks |pdf=|usr=}}
| + | |
| − | {{tp|p=32317197|t=ä. Health anxiety and behavioural changes of pregnant women during the COVID-19 pandemic |pdf=|usr=}}
| + | |
| − | {{tp|p=32350453|t=ä. SARS-CoV-2 self-isolation: recommendations for people with a vision impairment |pdf=|usr=}}
| + | |
| − | {{tp|p=32279023|t=2020. Epidemic psychiatry: The opportunities and challenges of COVID-19 |pdf=|usr=}}
| + | |
| − | {{tp|p=32215365|t=2020. A nationwide survey of psychological distress among Chinese people in the COVID-19 epidemic: implications and policy recommendations |pdf=|usr=}}
| + | |
| − | {{tp|p=32367286|t=ä. May home confinement during the COVID-19 outbreak worsen the global burden of myopia?|pdf=|usr=}}
| + | |
| | | | |
| | | | |
| | *'''[[Avoiding clinical medicine in other diseases]]''' | | *'''[[Avoiding clinical medicine in other diseases]]''' |
| | + | |
| | | | |
| | | | |
| | *'''[[Occupational medicine, workplace security and status hygienicus]]''' | | *'''[[Occupational medicine, workplace security and status hygienicus]]''' |
| | + | |
| | + | |
| | *'''[[Economic aspects of the status hygienicus]]''' | | *'''[[Economic aspects of the status hygienicus]]''' |
| − | {{tp|p=32300537|t=ä. The economic impact of the Coronavirus 2019 (Covid-2019): Implications for the mining industry |pdf=|usr=}}
| |
| − | {{tp|p=32331259|t=2020. The Food Systems in the Era of the Coronavirus (COVID-19) Pandemic Crisis |pdf=|usr=}}
| |
| | | | |
| | | | |
| | *'''[[Educational aspects of the status hygienicus]]''' | | *'''[[Educational aspects of the status hygienicus]]''' |
| − | *
| + | ---- |
| − | *'''[[Host, vector, one health, atmospheric aspects]]'''
| + | |
| | | | |
| | | | |
| | + | *'''[[Host, vector, one health, atmospheric aspects]]''' |
| | | | |
| | *'''[[Origin of Covid19]]''' | | *'''[[Origin of Covid19]]''' |
| − | {{tp|p=32315281|t=2020. Possible Bat Origin of Severe Acute Respiratory Syndrome Coronavirus 2 |pdf=|usr=}}
| + | |
| − | {{tp|p=32315626|t=2020. Probable Pangolin Origin of SARS-CoV-2 Associated with the COVID-19 Outbreak |pdf=|usr=}}
| + | *'''[[Epidemiology]]''' |
| − | {{tp|p=32148173|t=2020. Is SARS-CoV-2 originated from laboratory? A rebuttal to the claim of formation via laboratory recombination |pdf=|usr=}}
| + | |
| − | {{tp|p=32102621|t=2020. No credible evidence supporting claims of the laboratory engineering of SARS-CoV-2 |pdf=|usr=}}
| + | |
| − | {{tp|p=32056509|t=2020. HIV-1 did not contribute to the 2019-nCoV genome |pdf=|usr=}}
| + | |
| − | {{tp|p=32373134|t=2020. Commentary: Origin and evolution of pathogenic coronaviruses |pdf=|usr=}}
| + | |
| | | | |
| | *'''[[Remission, recurrence and persistence]]''' | | *'''[[Remission, recurrence and persistence]]''' |
| − | {{tp|p=32183934|t=2020. Post-discharge surveillance and positive virus detection in two medical staff recovered from coronavirus disease 2019 (COVID-19), China, January to February 2020 |pdf=|usr=}}
| |
| | | | |
| − | *'''[[Epidemiology]]'''
| |
| − | {{tp|p=32341172|t=2020. Suspected cases of COVID-19: study protocol for reporting characteristics and the outcomes |pdf=|usr=}}
| |
| − | {{tp|p=32279219|t=ä. Phase- and epidemic region-adjusted estimation of the number of coronavirus disease 2019 cases in China |pdf=|usr=}}
| |
| − | {{tp|p=32212059|t=ä. COVID-19 containment: China provides important lessons for global response |pdf=|usr=}}
| |
| − | {{tp|p=32212058|t=ä. Protecting healthcare personnel from 2019-nCoV infection risks: lessons and suggestions |pdf=|usr=}}
| |
| − | {{tp|p=32172487|t=ä. Back to the spring of Wuhan: facts and hope of COVID-19 outbreak |pdf=|usr=}}
| |
| − | {{tp|p=32166600|t=ä. China?s local governments are combating COVID-19 with unprecedented responses ? from a Wenzhou governance perspective |pdf=|usr=}}
| |
| − | {{tp|p=32328496|t=2020. Coronavirus Disease (COVID-19) in Italy: Analysis of Risk Factors and Proposed Remedial Measures |pdf=|usr=}}
| |
| − | {{tp|p=32373620|t=2020. Is Pakistan s Response to Coronavirus (SARS-CoV-2) Adequate to Prevent an Outbreak?|pdf=|usr=}}
| |
| − | {{tp|p=32308940|t=2020. Predicting the mortality due to Covid-19 by the next month for Italy, Iran and South Korea; a simulation study |pdf=|usr=}}
| |
| − | {{tp|p=32274354|t=2020. SARS-CoV-2 in Romania ? situation update and containment strategies |pdf=|usr=}}
| |
| − | {{tp|p=32226823|t=2020. The novel coronavirus outbreak in Wuhan, China |pdf=|usr=}}
| |
| − | {{tp|p=32166128|t=2020. The novel coronavirus outbreak: what can be learned from China in public reporting?|pdf=|usr=}}
| |
| − | {{tp|p=32158961|t=2020. First two months of the 2019 Coronavirus Disease (COVID-19) epidemic in China: real-time surveillance and evaluation with a second derivative model |pdf=|usr=}}
| |
| − | {{tp|p=32313361|t=ä. Smart technologies for fighting pandemics: The techno- and human- driven approaches in controlling the virus transmission |pdf=|usr=}}
| |
| − | {{tp|p=32322654|t=2020. The most eagerly awaited summer of the Anthropocene: A perspective of SARS-CoV-2 decay and seasonal change |pdf=|usr=}}
| |
| − | {{tp|p=32146554|t=ä. Containing 2019-nCoV (Wuhan) coronavirus |pdf=|usr=}}
| |
| − | {{tp|p=32368712|t=2020. Are Clinicians Contributing to Excess African American COVID-19 Deaths? Unbeknownst to Them, They May Be |pdf=|usr=}}
| |
| − | {{tp|p=32341908|t=ä. Diagnostic and digital solutions to address the COVID-19 pandemic: The need for international collaboration to close the gap |pdf=|usr=}}
| |
| − | {{tp|p=32289004|t=2020. A new pandemic out of China: the Wuhan 2019-nCoV coronavirus syndrome |pdf=|usr=}}
| |
| − | {{tp|p=32322475|t=ä. Defending against the Novel Coronavirus (COVID-19) Outbreak: How Can the Internet of Things (IoT) help to save the World?|pdf=|usr=}}
| |
| − | {{tp|p=32297931|t=ä. Why health promotion matters to the COVID-19 pandemic, and vice versa |pdf=|usr=}}
| |
| − | {{tp|p=32197274|t=2020. COVID?19: Vulnerability and the power of privilege in a pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32296619|t=2020. Battle against novel coronavirus 2019-nCoV: International commitment to develop worldwide informing campaigns |pdf=|usr=}}
| |
| − | {{tp|p=32372664|t=2020. Mexico: Lessons learned from the 2009 pandemic that help us fight COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32245157|t=2020. Effective Risk Communication for Public Health Emergency: Reflection on the COVID-19 (2019-nCoV) Outbreak in Wuhan, China |pdf=|usr=}}
| |
| − | {{tp|p=32120822|t=2020. On the Coronavirus (COVID-19) Outbreak and the Smart City Network: Universal Data Sharing Standards Coupled with Artificial Intelligence (AI) to Benefit Urban Health Monitoring and Management |pdf=|usr=}}
| |
| − | {{tp|p=32326512|t=2020. Epidemiology of Coronavirus COVID-19: Forecasting the Future Incidence in Different Countries |pdf=|usr=}}
| |
| − | {{tp|p=32289090|t=2020. Investigating the cases of novel coronavirus disease (COVID-19) in China using dynamic statistical techniques |pdf=|usr=}}
| |
| − | {{tp|p=32361715|t=2020. Clinical trials and the COVID-19 pandemic |pdf=|usr=}}
| |
| | | | |
| | | | |
| | + | *'''[[Failure of executive measures]]''' |
| | + | ---- |
| | *'''[[Failure of politics and public health guidance]]''' | | *'''[[Failure of politics and public health guidance]]''' |
| − | {{tp|p=32363133|t=ä. The Inadequacy of Regulatory Frameworks in Time of Crisis and in Low-Resource Settings: Personal Protective Equipment and COVID-19 |pdf=|usr=}}
| |
| | | | |
| − | *'''[[Failure of executive measures]]'''
| + | |
| | *'''[[Political abuse of Covid19]]''' | | *'''[[Political abuse of Covid19]]''' |
| − | {{tp|p=C7152572|t=ä. Coronavirus Goes Viral: Quantifying the COVID-19 Misinformation Epidemic on Twitter |pdf=|usr=}}
| + | |
| − | {{tp|p=32241328|t=ä. Limited Early Warnings and Public Attention to Coronavirus Disease 2019 in China, January?February, 2020: A Longitudinal Cohort of Randomly Sampled Weibo Users |pdf=|usr=}}
| + | |
| − | {{tp|p=32332201|t=2020. Infodemic and the spread of fake news in the COVID-19-era |pdf=|usr=}}
| + | |
| | | | |
| | *'''[[Lost people]]''' | | *'''[[Lost people]]''' |
| | + | |
| | *'''[[Lost civilization]]''' | | *'''[[Lost civilization]]''' |
| − | {{tp|p=32345850|t=2020. Collateral damage of the COVID-19 outbreak: expression of concern |pdf=|usr=}}
| + | |
| | + | ---- |
| | + | |
| | | | |
| | *'''[[History of covid19 exploration]]''' | | *'''[[History of covid19 exploration]]''' |
| − | *'''[[Current state of coviki.org]]'''
| |
| − | *[[PubMed selected papers unsorted to be listed in contents topics]]
| |
| − | *[[coviki state of development]]
| |
| | *'''[[misc.]]''' | | *'''[[misc.]]''' |
| − | {{tp|p=32038538|t=2019. Transmissible Gastroenteritis Virus Infection Up-Regulates FcRn Expression via Nucleocapsid Protein and Secretion of TGF-? in Porcine Intestinal Epithelial Cells |pdf=|usr=}}
| |
| − | {{tp|p=32281753|t=2020. More questions than answers, and a way ahead|pdf=|usr=}}
| |
| − | {{tp|p=32371110|t=ä. Is it Crohn?s disease?|pdf=|usr=}}
| |
| − | {{tp|p=32247691|t=ä. Fighting the battle against SARS-CoV-2 as gastroenterologists in Italy |pdf=|usr=}}
| |
| − | {{tp|p=32239213|t=ä. Critical health literacy and the COVID-19 crisis |pdf=|usr=}}
| |
| − | {{tp|p=32360303|t=ä. COVID-19 Pandemic: the long and difficult way back to work |pdf=|usr=}}
| |
| − | {{tp|p=32373463|t=ä. To the Editor?Is it really COVID-19?|pdf=|usr=}}
| |
| | | | |
| | + | |
| | + | *'''[[Research tools]]''' |
| | + | |
| | + | |
| | + | |
| | + | |
| | + | {{tp|p=27490990|t=2017. AVCpred: an integrated web server for prediction and design of antiviral compounds |pdf=|usr=}} |
| | + | {{tp|p=25040500|t=2014. Engineering large viral DNA genomes using the CRISPR?Cas9 system |pdf=|usr=}} |
| | + | |
| | + | |
| | + | *'''[[PrePrint scene]]''' |
| | | | |
| | | | |
| | *'''[[from the ads]]''' | | *'''[[from the ads]]''' |
| − | *[http://www.okaybio.com covid19 antibodies, proteins & reagents] | + | |
| − | *[http://www.reactionbiology.com 700 kinsse assays] | + | *'''[[Current state of coviki.org]]''' |
| | + | *'''[[on-topic personal thoughts]]''' |
